ArticleThe breast journal2021

COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience.

Maddalena Barba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.